Legal Questions

May the insurer raise and investigate a Mallela (fraudulent incorporation) defense, or is it precluded, waived or denied discovery?

A decision decides this question when it rules on whether the insurer may pursue a Mallela ground (ineligibility under 11 NYCRR 65-3.16 [a] [12] because of who owns, controls or formed the provider) in the case before it, without deciding whether the provider is in fact ineligible: whether the defense is precluded by an untimely or absent denial or waived by not pleading it; whether leave to amend the answer to add it is granted; whether discovery, depositions, subpoenas, EUO questions or claim-verification requests aimed at ownership, control and finances are allowed, and on what showing (good cause, founded belief, case-specific or detailed allegations, good-faith basis); whether the provider's failure to object or to comply with such demands leads to an order to produce, a CPLR 3212 (f) denial or dismissal; whether collateral estoppel or a prior ruling bars or does not bar the defense; whether an arbitrator may refuse to hear it; whether it reaches bills for services before April 4, 2002; and whether an insurer's declaratory or recoupment claim on this ground may proceed.

Settled at the Appellate Division, no conflicting department. The Court of Appeals has not decided the procedural questions. Mallela (2005) said, without it being the question certified, that carriers may delay payment to investigate only for good cause and, in the licensing context, must show behavior tantamount to fraud; Carothers (2019) later held fraud is not required for the defense itself. The settled rules come from the Second Department: the defense is not precluded by an untimely denial (Acuhealth, 4564 [2017], reviewing a master arbitrator; the Appellate Term since 2006: 9782, 9748, 9624, 9256, 16609, 4294) and is not waived by failing to plead it (16609, 7508, 6988); discovery in a declaratory action needs no 'good cause' (One Beacon, 8832 [2008]); in collection actions the Appellate Term allows Mallela discovery on 'sufficient allegations' or 'detailed and specific reasons' (16609, 8586, 8468), not on conclusory ones (7508), and treats unchallenged demands as not palpably improper because the defense is not precludable (4294, 17491, 3559); and since 2025 it holds that ownership and finance documents may be requested as claim verification (Burke, 11424 and the series 11422-11647). Limits: an arbitrator may still refuse a late-submitted Mallela defense (Acuhealth, 3299 [2019]). The First Department has only assumed non-preclusion (Valdan, 4556 [2017]) and held a billing-fraud defense labelled Mallela precludable (Bay Needle, 3808 [2018]); its Appellate Term requires good cause or case-specific allegations before discovery (9516 [2006], 6820 [2012]). The threshold for discovery is worded differently across courts (good cause, founded belief, good-faith or reasonable basis, case-specific allegations), but no appellate court in either department allows Mallela discovery on mere suspicion. Trial courts split on verification-stage demands before 2025 (against: 7954, 7188, 6928, 7064, 6856, 6824, 4520; 11259 [2024, First Department trial court] still treats EUO document demands as pre-action discovery; for: 2159, 3267, 2161).

Leading authorities · Authority map · Decisions by court · Plain-text version (Markdown)

Leading authorities

  • State Farm Mut. Auto. Ins. Co. v Mallela (2005 NY Slip Op 02416) Court of Appeals, 2005Carriers may investigate licensing, but delay payment only for good causeCarriers may look beyond licensing documents to withhold payment from fraudulently incorporated providers; the regulations allow them to delay payment to investigate only for good cause, which in the licensing context requires behavior tantamount to fraud, not technical violations. No fraud or unjust-enrichment claim lies for payments made before April 4, 2002.
    demand that carriers delay the payment of claims to pursue investigations solely for good cause (see 11 NYCRR 65-3.2 [c]). In the licensing context, carriers will be unable to show “good cause” unless they can demonstrate behavior tantamount to fraud.
    Later history: Carothers (3315, 2019) clarified that Mallela does not require a finding of fraud for the defense itself. Lower courts disagree whether the good-cause passage governs litigation discovery (no: One Beacon, 8832; 16106) or only claim verification.
  • Matter of Acuhealth Acupuncture, P.C. v Country-Wide Ins. Co. (2017 NY Slip Op 02785) Appellate Division, Second Department, 2017Second Department: Mallela defense not precluded by untimely denialA master arbitrator correctly held that an arbitrator erred in treating the carrier's fraudulent incorporation (Mallela) defense as precluded because it was not raised in a timely denial; the master arbitrator's award was reinstated.
    the master arbitrator correctly found that the arbitrator had erroneously held that the carrier’s claim of fraudulent incorporation (see State Farm Mut. Auto. Ins. Co. v Mallela, 4 NY3d 313, 322 [2005]), was precluded because it was not raised in a timely denial
    Later history: Followed by the Appellate Term (4294, 17491, 3559). In a separate Acuhealth proceeding (3299, 2019) the Second Department held an arbitrator may refuse to consider a late-submitted Mallela defense. The First Department has only assumed non-preclusion (4556, 2017).
  • One Beacon Ins. Group, LLC v Midland Med. Care, P.C. (2008 NY Slip Op 06813) Appellate Division, Second Department, 2008Second Department: no good cause needed for Mallela discoveryIn an insurer's declaratory action, financial discovery on the fraudulent-incorporation claims was properly ordered; the insurer did not have to show 'good cause' under Mallela because the documents were material and necessary under CPLR 3101 (a).
    The Supreme Court properly granted that branch of the plaintiffs’ cross motion which was for disclosure of certain financial documents. Contrary to the appellants’ contention, the plaintiffs were not required to make a showing of “good cause” for such disclosure
    Later history: Also an anchor of fraudulent-incorporation for its ownership/control holding (triable issue).
  • Lexington Acupuncture, P.C. v General Assur. Co. (2012 NY Slip Op 22047) Appellate Term, Second Department, 2012Discovery allowed on sufficient allegations; defense non-waivable even unpleadedAlthough the insurer never pleaded or moved to add a Mallela defense, its allegations (investigator affidavits tying the owner to insurance-fraud figures) were sufficient to compel financial discovery and the owner's deposition; a Mallela defense is nonwaivable and may be asserted at any time notwithstanding the absence of a timely denial.
    Where, as here, an insurer requests discovery concerning a Mallela defense, the request should be granted as long as there are sufficient allegations supporting such a defense
    Later history: Cited by the Appellate Division in Acuhealth (4564, 2017).
  • Pomona Med. Diagnostic P.C. v Adirondack Ins. Co. (2012 NY Slip Op 51165(U)) Appellate Term, First Department, 2012First Department: no Mallela discovery without case-specific allegationsAn order compelling discovery was reversed: the insurer set forth no case-specific allegations supporting its fraudulent-incorporation defense and could not use pretrial discovery as a fishing expedition on mere suspicions.
    Nor has defendant set forth any case-specific allegations in support of its defense that plaintiff was fraudulently incorporated so as to justify discovery on this issue
    Later history: Followed by trial courts (2573, 3267, 6284) and quoted by the Appellate Term in 15793 (2026).
  • Burke 2 Physical Therapy, P.C. v State Farm Mut. Auto. Ins. Co. (2025 NY Slip Op 50195(U)) Appellate Term, Second Department, 2025Mallela documents may be requested as claim verificationThe insurer properly requested management agreements, W-2 forms, bank records and leases during claim verification to determine whether the provider was ineligible under the licensing rules; otherwise insurers would have to pay and sue for recoupment or wait for litigation and risk interest and fees. The provider's objection that the requests were nullities was no reasonable justification, so the complaint was dismissed.
    it was not improper for defendant to seek, during the claim verification stage, information—such as management agreements, W-2 forms, business-related bank records and lease agreements—for the purpose of determining whether plaintiff was ineligible to collect no-fault benefits due to a failure to meet licensing requirements
    Later history: Decided with Burke 11422 and 11426 (2025) and followed in 11479, 11622, 11637, 11647 and trial decisions 11498 (2025) and 15736 (2026).
  • Central Gen. Hosp. v Chubb Group of Ins. Cos. 90 NY2d 195Lack-of-coverage exception to preclusion; the Appellate Term relied on it in holding the Mallela defense not precluded (9782).Not in our database.
  • Presbyterian Hosp. in City of N.Y. v Maryland Cas. Co. 90 NY2d 274The 30-day preclusion rule the Mallela defense is held to escape.Not in our database.
  • 11 NYCRR 65-3.2 (c), 65-3.5 (b), (o) regulationsGood-reason requirement for verification and the verification procedure under which Mallela documents are requested (Mallela; Burke).Not in our database.
  • CPLR 3101 (a), 3025 (b), 3122 (a), 3212 (f), 3126 statutesMaterial-and-necessary discovery, leave to amend, time to object to demands, premature summary judgment, and sanctions for refusing disclosure: the provisions most Mallela procedure decisions apply.Not in our database.

Authority map

Each circle is a decision on this question, placed by court and date; its colour is the position it took. Lines are citations between them. Select a circle (or find a decision by name) to see its links and summary. The same decisions are listed by court below the map.

Insurer may raise or investigate the Mallela defense hereInsurer may not pursue or investigate the Mallela defense hereRing: rules on the question, but another ground decided the caseContrasted, distinguished or limitedDeclined to follow, questioned, overruled or reversedCited
Layout

The map loads when you scroll to it.

How the rule was applied, by court

Decisions (159)

Every decision in our database that rules on this question: highest court first, then by department, newest first. 46 turn on it; the others rule on it alongside a different main ground (marked "also decides"). The one-sentence summaries describe what each court said on this question.

How this page is made: the decisions are those in our case-law database that cite this question's leading cases or were tagged with its subject. A language model read each one in full and recorded whether it rules on the question, the position it took and a one-sentence summary; a second, independent reading checked every entry. Court, department, date and the citation links come from the database. Read the decision before relying on it.